Management of Bilateral Supraclavicular Adenopathy

Initial Evaluation and Diagnostic Approach

The National Comprehensive Cancer Network recommends that the next step in managing bilateral supraclavicular adenopathy in a pediatric patient should be a lymph node biopsy, preferably an excisional biopsy, to establish a definitive diagnosis, as supraclavicular lymphadenopathy carries a high risk for serious pathology including lymphoma, tuberculosis, and other malignancies 1
Excisional biopsy is preferred over fine needle aspiration (FNA) for initial diagnosis of lymphoma, as it provides more tissue for diagnostic testing and ancillary studies, with a strength of evidence based on expert consensus and clinical practice guidelines 2
For supraclavicular nodes specifically, the NCCN guidelines recommend following the workup recommendations for occult primary in the head and neck region, which includes a thorough physical examination, laboratory tests, and imaging studies 1

A CT scan of the chest, abdomen, and pelvis should be considered to evaluate for other sites of lymphadenopathy and potential primary malignancy, with a moderate level of evidence supporting its use in this context 3
In cases where lymphoma is suspected, PET-CT may be valuable for staging, with a high level of evidence supporting its use in this context, particularly for identifying areas of high metabolic activity 3
Ultrasound of the axilla can help characterize the lymphadenopathy but is insufficient as the sole diagnostic test, with a low level of evidence supporting its use in this context 4

Adequate immunophenotyping should be established if lymphoma is suspected, including a recommended panel for paraffin section immunohistochemistry and cell surface marker analysis by flow cytometry, with a high level of evidence supporting the importance of accurate immunophenotyping in lymphoma diagnosis 2

Relying solely on FNA when lymphoma is in the differential diagnosis may lead to inadequate tissue for definitive diagnosis, with a moderate level of evidence supporting the limitations of FNA in this context 2
COVID-19 vaccination can cause transient lymphadenopathy, but this should not be assumed as the cause without proper investigation, especially in supraclavicular location, with a low level of evidence supporting the association between COVID-19 vaccination and lymphadenopathy 5, 6

If initial biopsy is non-diagnostic but clinical suspicion remains high, rebiopsy should be considered, with a moderate level of evidence supporting the importance of repeat biopsy in cases where the initial diagnosis is unclear 2